医薬品医療機器総合機構（PMDA）で新たに開始した薬事戦略相談事業について

DOI Web Site Web Site PubMed

書誌事項

タイトル別名
  • Pharmaceuticals and Medical Devices Agency (PMDA)'s New Action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy
  • イヤクヒン イリョウ キキ ソウゴウ キコウ(PMDA)デ アラタ ニ カイシ シタ ヤクジ センリャク ソウダン ジギョウ ニ ツイテ

この論文をさがす

抄録

  Universities, research institutions, and venture capitals that possess promising “seed” research or technologies in Japan, are not always familiar with development strategies that lead to commercialization of the products in spite of their excellent science and research. In order to create innovative pharmaceuticals and medical devices originating from Japan, Pharmaceuticals and Medical Devices Agency (PMDA) launched new scientific consultation service, named ‘Pharmaceutical Affairs Consultation on R&D Strategy’ for universities, research institutions, and venture capitals on July 1, 2011. Through these consultations, the guidance and advice on the tests needed in the early development stage and the necessary clinical trials would be provided toward commercialization.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 133 (2), 183-186, 2013-02-01

    公益社団法人 日本薬学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ